Study summary

The purpose of the study is to assess efficacy and safety of a single treatment of Capsaicin 8% transdermal delivery system in reducing pain from damaged nerves (neuropathic pain) caused by diabetes.

Additional Study Details

Phase
Phase 3
Product
  • Capsaicin 8%
  • Placebo
  • Type
    Interventional
    Masking
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Enrollment number
    369
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A study to evaluate efficacy and safety of a single application of Capsaicin 8%transdermal delivery system compared to placebo in reducing pain intensity in subjects with Painful Diabetic Peripheral Neuropathy (PDPN)? Contact us by filling out your information to the right and we’ll respond to you.

    • A caregiver
    • A healthcare provider
    • A parent
    • A patient
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site: 125
      Anniston, Alabama, United States, 36207
      Withdrawn
      Site: 109
      Birmingham, AL, United States, 35216
      Withdrawn
      Site:104
      Birmingham, AL, United States, 35216
      Completed
      Site: 131
      Fresno, California, United States, 93720
      Completed
      Site: 123
      Long Beach, California, United States, 90806
      Completed
      Site: 116
      Los Angeles, CA, United States, 90033
      Terminated
      Site: 112
      Orange, CA, United States, 92868
      Completed
      Site: 130
      Walnut Creek, California, United States, 94597
      Terminated
      Site: 113
      Milford, CT, United States, 06460
      Completed
      Site: 119
      New London, Connecticut, United States, 06320
      Completed
      Site: 117
      Boynton Beach, Florida, United States, 33435
      Completed
      Site: 124
      Bradenton, Florida, United States, 34205
      Completed
      Site: 107
      Clearwater, FL, United States, 33765
      Completed
      Site: 120
      Jupiter, Florida, United States, 33458
      Withdrawn
      Site: 101
      Miramar, FL, United States, 33027
      Completed
      Site: 108
      Orlando, FL, United States, 32806
      Completed
      Site: 132
      Oviedo, Florida, United States, 32765
      Completed
      Site: 127
      St. Petersburg, Florida, United States, 33709
      Completed
      Site: 122
      Tampa, Florida, United States, 33606
      Completed
      Site: 133
      Honolulu, Hawaii, United States, 96814
      Completed
      Site: 126
      New Bedford, Massachusetts, United States, 02740
      Completed
      Site: 115
      Ann Arbor, MI, United States, 48104
      Completed
      Site: 128
      Hazelwood, Missouri, United States, 63042
      Completed
      Site:111
      New York, NY, United States, 10029
      Terminated
      Site: 110
      Winston-Salem, NC, United States, 27103
      Completed
      Site: 121
      Kettering, Ohio, United States, 45429
      Terminated
      Site:106
      Dallas, TX, United States, 75230
      Completed
      Site: 114
      Houston, TX, United States, 77098
      Completed
      Site: 118
      Houston, Texas, United States, 77030
      Completed
      Site: 103
      Lubbock, TX, United States, 79410
      Completed
      Site: 105
      San Antonio, TX, United States, 78228
      Terminated
      Site: 102
      San Antonio, TX, United States, 78229

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?